Etablissement Français du Sang
40
5
8
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
15.0%
6 terminated/withdrawn out of 40 trials
77.8%
-8.7% vs industry average
8%
3 trials in Phase 3/4
5%
1 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.
Role: collaborator
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
Role: collaborator
A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis
Role: collaborator
Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis
Role: collaborator
Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma
Role: collaborator
grouP O wholE blooD : storagE leSion impacT And infLammation
Role: lead
Neutralizing Interferon Type 1 in Hidradenitis Suppurativa
Role: collaborator
T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.
Role: collaborator
Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease
Role: collaborator
Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort
Role: collaborator
Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)
Role: collaborator
Impact of the Composition of Packed Red Blood Cell Supernatant on Renal Dysfunction and Posttransfusion Immunomodulation
Role: collaborator
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
Role: collaborator
AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells
Role: collaborator
Platelet Dysfunction in Blood Donors
Role: lead
Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP)
Role: lead
Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
Role: collaborator
Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1
Role: collaborator
Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.
Role: collaborator
Aortic Laryngeal Rehabilitation Graft
Role: collaborator